Literature DB >> 23142143

Noxious stimulation excites serotonergic neurons: a comparison between the lateral paragigantocellular reticular and the raphe magnus nuclei.

Rémi Gau1, Caroline Sévoz-Couche, Michel Hamon, Jean-François Bernard.   

Abstract

The present study was designed to record electrophysiological responses to graded noxious thermal stimuli of serotonergic and nonserotonergic neurons in the lateral paragigantocellular reticular (LPGi) and the raphe magnus (RMg) nuclei in rats. All of the neurons recorded were juxtacellularly filled with neurobiotin and identified with double immunofluorescent labeling for both neurobiotin and serotonin. Under halothane anesthesia (0.75%), noxious thermal stimuli ⩾48°C activated almost all (88%) of the serotonergic neurons located within the LPGi (n=16). The increase in firing was clear (3.4±0.3spike/s: mean of responses above the population median) and sustained during the whole application of strong thermal noxious stimuli, with a high mean threshold (48.3±0.3°C) and large receptive fields. Recording of serotonergic neurons in the RMg (n=21) demonstrated that the proportion of strongly activated (>2spike/s) neurons (19% vs 59% for the LPGi) as well as the magnitude of the activation (2.1±0.4spike/s: mean of responses above the population median) to thermal noxious stimuli were significantly lower than in the LPGi (P<.05). Within the boundaries of both the LPGi and the RMg (B3 group), nonserotonergic neurons were also predominantly excited (75%) by noxious stimuli, and the resulting activation (7.9±1.2spike/s) was even greater than that of serotonergic neurons. Thermal noxious stimuli-induced activation of LPGi serotonergic cells probably plays a key role in serotonin-mediated modulations of cardiac baroreflex and transmission of nociceptive messages occurring under such intense noxious conditions.
Copyright © 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142143     DOI: 10.1016/j.pain.2012.09.012

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  6 in total

1.  Neuropeptide Y in the rostral ventromedial medulla reverses inflammatory and nerve injury hyperalgesia in rats via non-selective excitation of local neurons.

Authors:  D R Cleary; Z Roeder; R Elkhatib; M M Heinricher
Journal:  Neuroscience       Date:  2014-04-30       Impact factor: 3.590

Review 2.  Shifting the Balance: How Top-Down and Bottom-Up Input Modulate Pain via the Rostral Ventromedial Medulla.

Authors:  Qiliang Chen; Mary M Heinricher
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-28

3.  On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation.

Authors:  Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Alicia Rivera; Kathleen Van Craenenbroeck; Alexander O Tarakanov; Luigi F Agnati; Kjell Fuxe
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-17       Impact factor: 2.629

4.  Differential innervation of superficial versus deep laminae of the dorsal horn by bulbo-spinal serotonergic pathways in the rat.

Authors:  A Gautier; D Geny; S Bourgoin; J F Bernard; M Hamon
Journal:  IBRO Rep       Date:  2017-04-09

5.  Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain.

Authors:  Franck Aby; Louis-Etienne Lorenzo; Zoé Grivet; Rabia Bouali-Benazzouz; Hugo Martin; Stéphane Valerio; Sara Whitestone; Dominique Isabel; Walid Idi; Otmane Bouchatta; Philippe De Deurwaerdere; Antoine G Godin; Cyril Herry; Xavier Fioramonti; Marc Landry; Yves De Koninck; Pascal Fossat
Journal:  Sci Adv       Date:  2022-07-27       Impact factor: 14.957

6.  Modality selective roles of pro-nociceptive spinal 5-HT2A and 5-HT3 receptors in normal and neuropathic states.

Authors:  Ryan Patel; Anthony H Dickenson
Journal:  Neuropharmacology       Date:  2018-09-18       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.